Otc - Active Ingredient
ACTIVE INGREDIENT:
Hydrocortisone 1%
Dermaquest Skin Therapy Post-skin Resurfacing Balm
FDA Label NDC 62742-4051
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Allure Labs, Inc. for the product Dermaquest Skin Therapy Post-skin Resurfacing Balm (NDC 62742-4051). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - keep out of reach of children, dosage & administration, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Purpose
PURPOSE:
Anti-itch
Indications & Usage
USES:
- promotes healing of itchy skin
- keeps skin hydrated
Warnings
WARNINGS:
For external use only.
Ask a doctor if bleeding occurs or conditions worsens
Otc - Keep Out Of Reach Of Children
Keep out of reach of chilren.
If swallowed get medical help or contact a Poison Control Center right away.
Dosage & Administration
DIRECTIONS:
Apply to the skin as instructed by your skincare professional to keep the skin hydrated and to promote healing.
Inactive Ingredient
INACTIVE INGREDIENTS:
Petrolatum, Tocopheryl Acetate (Vitamin E), Carthamus Tinctorius (Safflower) Seed Oil, Ubiquinone (Co-Enzyme Q10), Zinc Oxide (Cl 77947), Titanium Dioxide (Cl 77891), Ascorbyl Palmiate (Vitamin C), Glycosaminoglycans.
Package Label.Principal Display Panel
DISTRIBUTOR:
DermaQuest, Inc.
Hayward, CA
dermaquestinc.com
IMAGE OF PRINCIPAL DISPLAY PANEL:
Principal Display Panel: Post-skin Resurfacing Balm (Dqs054 V1 Image)
* Please review the disclaimer below.
